Syros Pharmaceuticals Inc (SYRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 1,101 | 0 | 0 | 0 | 0 |
| Gross Profit | 1,101 | N/A | N/A | N/A | N/A |
| Operating Expenses | 12,714 | 11,362 | 14,217 | 12,065 | 10,636 |
| Operating Income | -11,613 | -11,045 | -14,217 | -12,065 | -10,636 |
| Other Income | 98 | 80 | 48 | 44 | 48 |
| Pre-tax Income | -11,515 | -10,965 | -14,169 | -12,021 | -10,588 |
| Net Income Continuous | -11,515 | -10,965 | -14,169 | -12,021 | -10,588 |
| Net Income | $-11,515 | $-10,965 | $-14,169 | $-12,021 | $-10,588 |
| EPS Basic Total Ops | -4.90 | 71.70 | -6.50 | -54.20 | -51.50 |
| EPS Basic Continuous Ops | -4.92 | 60.14 | -6.44 | -47.09 | -44.23 |
| EPS Diluted Total Ops | -4.90 | 71.70 | -6.50 | -54.20 | -51.50 |
| EPS Diluted Continuous Ops | -4.92 | 60.14 | -6.44 | -47.09 | -44.23 |
| EBITDA(a) | $-11,248 | $-11,024 | $-13,902 | $-11,749 | $-10,332 |